Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Regulation of Tristetraprolin Expression by Interleukin-1β and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase

Elizabeth M. King, Manminder Kaur, Wei Gong, Christopher F. Rider, Neil S. Holden and Robert Newton
Journal of Pharmacology and Experimental Therapeutics August 2009, 330 (2) 575-585; DOI: https://doi.org/10.1124/jpet.109.151423
Elizabeth M. King
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manminder Kaur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Gong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher F. Rider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil S. Holden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Newton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

The mRNA-destabilizing protein tristetraprolin (TTP) negatively regulates adenine- and uridine-rich element (ARE)-containing mRNAs. In A549 pulmonary cells, TTP mRNA and both a ∼40- and a ∼45-kDa phosphorylated version of TTP protein were rapidly induced in response to interleukin (IL)-1β. Analysis with IκBαΔN, a dominant version of inhibitor of κBα (IκBα), as well as dominant-negative and small-molecule IκB kinase (IKK) inhibitors demonstrated that IL-1β-induced TTP is nuclear factor-κB (NF-κB)-dependent. Likewise, TTP expression and formation of the ∼45-kDa phosphorylated form of TTP are blocked by the p38 mitogen-activated protein kinase (MAPK) inhibitor 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580). By contrast, and despite a 3- to 4-fold induction of TTP mRNA, the anti-inflammatory glucocorticoid dexamethasone only modestly induced expression of the ∼40-kDa form of TTP. In the context of IL-1β, dexamethasone exerted a marginal repressive effect on TTP mRNA expression and more considerably reduced TTP protein. Given a requirement for p38 MAPK in the induction of TTP by IL-1β, this repressive effect may be explained by repression of the p38 MAPK pathway by dexamethasone. Knockdown of TTP protein by siRNA elevated IL-1β-induced expression of granulocyte macrophage–colony-stimulating factor (GM-CSF) and IL-8, demonstrating a role for TTP in feedback control. Likewise, knockdown of TTP increased GM-CSF expression in the presence of IL-1β plus dexamethasone, suggesting that feedback control by TTP also occurs in the context of IL-1β plus dexamethasone. Taken together, our data demonstrate that NF-κB and p38 MAPK are critical to the induction of TTP by IL-1β and that TTP induction provides feedback control of the ARE-containing genes GM-CSF and IL-8.

Footnotes

  • This study was supported by a start-up grant from the Alberta Heritage Foundation for Medical Research (to R.N.); the Canadian Institutes of Health Research [Grants 128534, 171818] (to R.N.); a Lung Association of Alberta and the North West Territories studentship (to E.M.K.); and an Izaak Walton Killam postdoctoral fellowship (to N.S.H.). Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund for Innovation and the Alberta Science and Research Authority. Work in the laboratory of R.N. was also supported by grants from AstraZeneca, GlaxoSmithKline, and Nycomed.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.109.151423.

  • ABBREVIATIONS: IL, interleukin; TNF, tumor necrosis factor; GM-CSF, granulocyte–macrophage colony-stimulating factor; NF-κB, nuclear factor-κB; ARE, adenine- and uridine-rich element; MAPK, mitogen-activated protein kinase; TTP, tristetraprolin; ERK, extracellular signal-regulated kinase; DMEM, Dulbecco's modified Eagle's medium; PD098059, 2′-amino-3′-methoxyflavone; U0126, 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene; SB203580, 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole; PS-1145, N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)-3-pyridinecarboxamide dihydrochloride; ML120B, N-(6-chloro-7-methoxy-9H-β-carbolin-8-yl)-2-methylnicotinamide; DMSO, dimethyl sulfoxide; MOI, multiplicity of infection; Ad, adenovirus; IκBα, inhibitor of κBα; IKK, IκB kinase; siRNA, short interfering RNA; GFP, green fluorescent protein; HA, hemagglutinin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PCR, polymerase chain reaction; CIAP, calf alkaline intestinal phosphatase; ANOVA, analysis of variance; MEK, mitogen-activated protein kinase kinase.

  • ↵ Embedded Image The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material.

    • Received January 25, 2009.
    • Accepted May 11, 2009.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 380 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 380, Issue 3
1 Mar 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Regulation of Tristetraprolin Expression by Interleukin-1β and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Regulation of Tristetraprolin Expression by Interleukin-1β and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase

Elizabeth M. King, Manminder Kaur, Wei Gong, Christopher F. Rider, Neil S. Holden and Robert Newton
Journal of Pharmacology and Experimental Therapeutics August 1, 2009, 330 (2) 575-585; DOI: https://doi.org/10.1124/jpet.109.151423

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleINFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Regulation of Tristetraprolin Expression by Interleukin-1β and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase

Elizabeth M. King, Manminder Kaur, Wei Gong, Christopher F. Rider, Neil S. Holden and Robert Newton
Journal of Pharmacology and Experimental Therapeutics August 1, 2009, 330 (2) 575-585; DOI: https://doi.org/10.1124/jpet.109.151423
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PK/PD of PDE Inhibitors in Autoimmune Hepatitis
  • Assessment of KPL-404, a CD40 antagonist
  • RCTR1 Promotes Alveolar Fluid Clearance
Show more Inflammation, Immunopharmacology, and Asthma

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics